Global Granulocyte Macrophage Colony Stimulating Factor Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Granulocyte Macrophage Colony Stimulating Factor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Granulocyte Macrophage Colony Stimulating Factor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Granulocyte Macrophage Colony Stimulating Factor market in any manner.
Global Granulocyte Macrophage Colony Stimulating Factor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
Market Segmentation (by Type)
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market Segmentation (by Application)
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Granulocyte Macrophage Colony Stimulating Factor Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Granulocyte Macrophage Colony Stimulating Factor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Granulocyte Macrophage Colony Stimulating Factor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Granulocyte Macrophage Colony Stimulating Factor market in any manner.
Global Granulocyte Macrophage Colony Stimulating Factor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
Market Segmentation (by Type)
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market Segmentation (by Application)
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Granulocyte Macrophage Colony Stimulating Factor Market
- Overview of the regional outlook of the Granulocyte Macrophage Colony Stimulating Factor Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Granulocyte Macrophage Colony Stimulating Factor Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Granulocyte Macrophage Colony Stimulating Factor
1.2 Key Market Segments
1.2.1 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
1.2.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET COMPETITIVE LANDSCAPE
3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2019-2024)
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2019-2024)
3.3 Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Granulocyte Macrophage Colony Stimulating Factor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Sales Sites, Area Served, Product Type
3.6 Granulocyte Macrophage Colony Stimulating Factor Market Competitive Situation and Trends
3.6.1 Granulocyte Macrophage Colony Stimulating Factor Market Concentration Rate
3.6.2 Global 5 and 10 Largest Granulocyte Macrophage Colony Stimulating Factor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR INDUSTRY CHAIN ANALYSIS
4.1 Granulocyte Macrophage Colony Stimulating Factor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2019-2024)
6.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Market Share by Type (2019-2024)
6.4 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2019-2024)
7 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Sales by Application (2019-2024)
7.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) by Application (2019-2024)
7.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
8 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY REGION
8.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region
8.2 North America
8.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Aduro BioTech Inc
9.1.1 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.1.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.1.4 Aduro BioTech Inc Business Overview
9.1.5 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.1.6 Aduro BioTech Inc Recent Developments
9.2 Amgen Inc
9.2.1 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.2.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.2.4 Amgen Inc Business Overview
9.2.5 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.2.6 Amgen Inc Recent Developments
9.3 BriaCell Therapeutics Corp
9.3.1 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.3.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.3.5 BriaCell Therapeutics Corp Business Overview
9.3.6 BriaCell Therapeutics Corp Recent Developments
9.4 Cold Genesys Inc
9.4.1 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.4.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.4.4 Cold Genesys Inc Business Overview
9.4.5 Cold Genesys Inc Recent Developments
9.5 GlaxoSmithKline Plc
9.5.1 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.5.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.5.4 GlaxoSmithKline Plc Business Overview
9.5.5 GlaxoSmithKline Plc Recent Developments
9.6 Humanigen Inc
9.6.1 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.6.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.6.4 Humanigen Inc Business Overview
9.6.5 Humanigen Inc Recent Developments
9.7 Mologen AG
9.7.1 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.7.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.7.4 Mologen AG Business Overview
9.7.5 Mologen AG Recent Developments
9.8 Morphotek Inc
9.8.1 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.8.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.8.4 Morphotek Inc Business Overview
9.8.5 Morphotek Inc Recent Developments
9.9 Sillajen Biotherapeutics
9.9.1 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.9.4 Sillajen Biotherapeutics Business Overview
9.9.5 Sillajen Biotherapeutics Recent Developments
9.10 Takeda Pharmaceutical Co Ltd
9.10.1 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.10.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.10.4 Takeda Pharmaceutical Co Ltd Business Overview
9.10.5 Takeda Pharmaceutical Co Ltd Recent Developments
10 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET FORECAST BY REGION
10.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast
10.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country
10.2.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region
10.2.4 South America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Granulocyte Macrophage Colony Stimulating Factor by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Granulocyte Macrophage Colony Stimulating Factor by Type (2025-2030)
11.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Granulocyte Macrophage Colony Stimulating Factor by Type (2025-2030)
11.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Application (2025-2030)
11.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) Forecast by Application
11.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Granulocyte Macrophage Colony Stimulating Factor
1.2 Key Market Segments
1.2.1 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
1.2.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET COMPETITIVE LANDSCAPE
3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2019-2024)
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturers (2019-2024)
3.3 Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Granulocyte Macrophage Colony Stimulating Factor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Sales Sites, Area Served, Product Type
3.6 Granulocyte Macrophage Colony Stimulating Factor Market Competitive Situation and Trends
3.6.1 Granulocyte Macrophage Colony Stimulating Factor Market Concentration Rate
3.6.2 Global 5 and 10 Largest Granulocyte Macrophage Colony Stimulating Factor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR INDUSTRY CHAIN ANALYSIS
4.1 Granulocyte Macrophage Colony Stimulating Factor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2019-2024)
6.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Market Share by Type (2019-2024)
6.4 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2019-2024)
7 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Sales by Application (2019-2024)
7.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) by Application (2019-2024)
7.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
8 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION BY REGION
8.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region
8.2 North America
8.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Aduro BioTech Inc
9.1.1 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.1.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.1.4 Aduro BioTech Inc Business Overview
9.1.5 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.1.6 Aduro BioTech Inc Recent Developments
9.2 Amgen Inc
9.2.1 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.2.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.2.4 Amgen Inc Business Overview
9.2.5 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.2.6 Amgen Inc Recent Developments
9.3 BriaCell Therapeutics Corp
9.3.1 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.3.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
9.3.5 BriaCell Therapeutics Corp Business Overview
9.3.6 BriaCell Therapeutics Corp Recent Developments
9.4 Cold Genesys Inc
9.4.1 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.4.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.4.4 Cold Genesys Inc Business Overview
9.4.5 Cold Genesys Inc Recent Developments
9.5 GlaxoSmithKline Plc
9.5.1 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.5.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.5.4 GlaxoSmithKline Plc Business Overview
9.5.5 GlaxoSmithKline Plc Recent Developments
9.6 Humanigen Inc
9.6.1 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.6.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.6.4 Humanigen Inc Business Overview
9.6.5 Humanigen Inc Recent Developments
9.7 Mologen AG
9.7.1 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.7.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.7.4 Mologen AG Business Overview
9.7.5 Mologen AG Recent Developments
9.8 Morphotek Inc
9.8.1 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.8.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.8.4 Morphotek Inc Business Overview
9.8.5 Morphotek Inc Recent Developments
9.9 Sillajen Biotherapeutics
9.9.1 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.9.4 Sillajen Biotherapeutics Business Overview
9.9.5 Sillajen Biotherapeutics Recent Developments
9.10 Takeda Pharmaceutical Co Ltd
9.10.1 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Basic Information
9.10.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Overview
9.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Market Performance
9.10.4 Takeda Pharmaceutical Co Ltd Business Overview
9.10.5 Takeda Pharmaceutical Co Ltd Recent Developments
10 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET FORECAST BY REGION
10.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast
10.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country
10.2.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region
10.2.4 South America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Granulocyte Macrophage Colony Stimulating Factor by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Granulocyte Macrophage Colony Stimulating Factor by Type (2025-2030)
11.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Granulocyte Macrophage Colony Stimulating Factor by Type (2025-2030)
11.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Application (2025-2030)
11.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) Forecast by Application
11.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Granulocyte Macrophage Colony Stimulating Factor Market Size Comparison by Region (M USD)
Table 5. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocyte Macrophage Colony Stimulating Factor as of 2022)
Table 10. Global Market Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Sales Sites and Area Served
Table 12. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Granulocyte Macrophage Colony Stimulating Factor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Granulocyte Macrophage Colony Stimulating Factor Market Challenges
Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (Kilotons)
Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Type (M USD)
Table 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Type (2019-2024)
Table 25. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2019-2024)
Table 26. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) by Type (2019-2024)
Table 27. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Share by Type (2019-2024)
Table 28. Global Granulocyte Macrophage Colony Stimulating Factor Price (USD/Ton) by Type (2019-2024)
Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Application
Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2019-2024)
Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2019-2024) & (M USD)
Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2024)
Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2019-2024)
Table 38. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 43. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 44. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 45. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Aduro BioTech Inc Business Overview
Table 47. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 48. Aduro BioTech Inc Recent Developments
Table 49. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 50. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 51. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Inc Business Overview
Table 53. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 54. Amgen Inc Recent Developments
Table 55. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 56. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 57. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 59. BriaCell Therapeutics Corp Business Overview
Table 60. BriaCell Therapeutics Corp Recent Developments
Table 61. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 62. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 63. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cold Genesys Inc Business Overview
Table 65. Cold Genesys Inc Recent Developments
Table 66. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 67. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 68. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc Business Overview
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 72. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 73. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Humanigen Inc Business Overview
Table 75. Humanigen Inc Recent Developments
Table 76. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 77. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 78. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Mologen AG Business Overview
Table 80. Mologen AG Recent Developments
Table 81. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 82. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 83. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Morphotek Inc Business Overview
Table 85. Morphotek Inc Recent Developments
Table 86. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 87. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 88. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sillajen Biotherapeutics Business Overview
Table 90. Sillajen Biotherapeutics Recent Developments
Table 91. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 92. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 93. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Takeda Pharmaceutical Co Ltd Business Overview
Table 95. Takeda Pharmaceutical Co Ltd Recent Developments
Table 96. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Granulocyte Macrophage Colony Stimulating Factor Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Granulocyte Macrophage Colony Stimulating Factor Market Size Comparison by Region (M USD)
Table 5. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Granulocyte Macrophage Colony Stimulating Factor as of 2022)
Table 10. Global Market Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Sales Sites and Area Served
Table 12. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Granulocyte Macrophage Colony Stimulating Factor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Granulocyte Macrophage Colony Stimulating Factor Market Challenges
Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (Kilotons)
Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Type (M USD)
Table 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Type (2019-2024)
Table 25. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2019-2024)
Table 26. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) by Type (2019-2024)
Table 27. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Share by Type (2019-2024)
Table 28. Global Granulocyte Macrophage Colony Stimulating Factor Price (USD/Ton) by Type (2019-2024)
Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) by Application
Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2019-2024)
Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2019-2024) & (M USD)
Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2024)
Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2019-2024)
Table 38. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2019-2024) & (Kilotons)
Table 43. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 44. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 45. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Aduro BioTech Inc Business Overview
Table 47. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 48. Aduro BioTech Inc Recent Developments
Table 49. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 50. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 51. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Inc Business Overview
Table 53. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 54. Amgen Inc Recent Developments
Table 55. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 56. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 57. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor SWOT Analysis
Table 59. BriaCell Therapeutics Corp Business Overview
Table 60. BriaCell Therapeutics Corp Recent Developments
Table 61. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 62. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 63. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cold Genesys Inc Business Overview
Table 65. Cold Genesys Inc Recent Developments
Table 66. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 67. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 68. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc Business Overview
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 72. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 73. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Humanigen Inc Business Overview
Table 75. Humanigen Inc Recent Developments
Table 76. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 77. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 78. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Mologen AG Business Overview
Table 80. Mologen AG Recent Developments
Table 81. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 82. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 83. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Morphotek Inc Business Overview
Table 85. Morphotek Inc Recent Developments
Table 86. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 87. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 88. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sillajen Biotherapeutics Business Overview
Table 90. Sillajen Biotherapeutics Recent Developments
Table 91. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Basic Information
Table 92. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Overview
Table 93. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Takeda Pharmaceutical Co Ltd Business Overview
Table 95. Takeda Pharmaceutical Co Ltd Recent Developments
Table 96. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Granulocyte Macrophage Colony Stimulating Factor Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD), 2019-2030
Figure 5. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) (2019-2030)
Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (M USD)
Figure 11. Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2023
Figure 12. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers in 2023
Figure 13. Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Granulocyte Macrophage Colony Stimulating Factor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Figure 18. Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2019-2024)
Figure 19. Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2023
Figure 20. Market Size Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2019-2024)
Figure 21. Market Size Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2019-2024)
Figure 25. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2023
Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2024)
Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2023
Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2019-2024)
Figure 30. North America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 32. U.S. Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Granulocyte Macrophage Colony Stimulating Factor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 37. Germany Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2023
Figure 44. China Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 50. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 51. Brazil Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Type (2025-2030)
Figure 65. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2025-2030)
Figure 66. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD), 2019-2030
Figure 5. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (M USD) (2019-2030)
Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (M USD)
Figure 11. Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2023
Figure 12. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers in 2023
Figure 13. Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Granulocyte Macrophage Colony Stimulating Factor Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Granulocyte Macrophage Colony Stimulating Factor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Type
Figure 18. Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2019-2024)
Figure 19. Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2023
Figure 20. Market Size Share of Granulocyte Macrophage Colony Stimulating Factor by Type (2019-2024)
Figure 21. Market Size Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application
Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2019-2024)
Figure 25. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2023
Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2024)
Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2023
Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate by Application (2019-2024)
Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2019-2024)
Figure 30. North America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 32. U.S. Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Granulocyte Macrophage Colony Stimulating Factor Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Granulocyte Macrophage Colony Stimulating Factor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 37. Germany Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2023
Figure 44. China Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 50. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2023
Figure 51. Brazil Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Type (2025-2030)
Figure 65. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2025-2030)
Figure 66. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Application (2025-2030)
